Literature DB >> 8293471

Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.

G W Kemble1, T Danieli, J M White.   

Abstract

It has been proposed that membrane fusion events such as virus-cell fusion proceed through a hemifusion intermediate, a state where lipids but not contents of the fusing compartments mix. We engineered the influenza hemagglutinin (HA) such that it would be anchored in membranes via a glycosylphosphatidylinositol (GPI) tail. GPI-anchored HA forms a trimer that can bind red blood cells (RBCs) and change conformation under fusion-inducing conditions. Using RBCs labeled with fluorescent lipid or fluorescent soluble content probes, we found that GPI-anchored HA mediated lipid mixing with similar time course and efficiency as wt-HA, yet did not mediate transfer of soluble contents. Hence, GPI-anchored HA appears to initiate, but not complete, a fusion reaction. We interpret our results as evidence for uncoupling a physiological fusion reaction, for trapping a hemifusion intermediate, and for assigning a role to a transmembrane domain in a fusion event.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8293471     DOI: 10.1016/0092-8674(94)90344-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  237 in total

1.  Role of the membrane-proximal domain in the initial stages of human immunodeficiency virus type 1 envelope glycoprotein-mediated membrane fusion.

Authors:  I Muñoz-Barroso; K Salzwedel; E Hunter; R Blumenthal
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge.

Authors:  V I Razinkov; G B Melikyan; F S Cohen
Journal:  Biophys J       Date:  1999-12       Impact factor: 4.033

3.  Evolution of intermediates of influenza virus hemagglutinin-mediated fusion revealed by kinetic measurements of pore formation.

Authors:  R M Markosyan; G B Melikyan; F S Cohen
Journal:  Biophys J       Date:  2001-02       Impact factor: 4.033

4.  A specific point mutant at position 1 of the influenza hemagglutinin fusion peptide displays a hemifusion phenotype.

Authors:  H Qiao; R T Armstrong; G B Melikyan; F S Cohen; J M White
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

5.  The role of the membrane-spanning domain sequence in glycoprotein-mediated membrane fusion.

Authors:  G M Taylor; D A Sanders
Journal:  Mol Biol Cell       Date:  1999-09       Impact factor: 4.138

6.  A new class of fusion-associated small transmembrane (FAST) proteins encoded by the non-enveloped fusogenic reoviruses.

Authors:  M Shmulevitz; R Duncan
Journal:  EMBO J       Date:  2000-03-01       Impact factor: 11.598

7.  Role of hemagglutinin surface density in the initial stages of influenza virus fusion: lack of evidence for cooperativity.

Authors:  S Günther-Ausborn; P Schoen; I Bartoldus; J Wilschut; T Stegmann
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

8.  Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins.

Authors:  B Kobe; R J Center; B E Kemp; P Poumbourios
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

9.  A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.

Authors:  G B Melikyan; R M Markosyan; M G Roth; F S Cohen
Journal:  Mol Biol Cell       Date:  2000-11       Impact factor: 4.138

10.  Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion.

Authors:  E Leikina; L V Chernomordik
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.